Huntington National Bank Boston Scientific Corp Transaction History

Huntington National Bank

  • $13.4 Billion
  • Q1 2025

A detailed history of Huntington National Bank transactions in Boston Scientific Corp stock. As of the latest transaction made, Huntington National Bank holds 1,350,212 shares of BSX stock, worth $141 Million. This represents 1.02% of its overall portfolio holdings.

Number of Shares
1,350,212
Previous 1,260,697 7.1%
Holding current value
$141 Million
Previous $113 Million 20.96%
% of portfolio
1.02%
Previous 0.82%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025
BUY
$89.38 - $106.18 $8 Million - $9.5 Million
89,515 Added 7.1%
1,350,212 $136 Million
Q4 2024

Feb 12, 2025
BUY
$83.62 - $91.5 $5.2 Million - $5.69 Million
62,141 Added 5.18%
1,260,697 $113 Million
Q3 2024

Nov 06, 2024
BUY
$72.96 - $84.0 $6.19 Million - $7.13 Million
84,830 Added 7.62%
1,198,556 $100 Million
Q2 2024

Aug 08, 2024
BUY
$67.33 - $77.71 $5.55 Million - $6.4 Million
82,416 Added 7.99%
1,113,726 $85.8 Million
Q1 2024

May 03, 2024
BUY
$57.6 - $68.62 $5.62 Million - $6.7 Million
97,600 Added 10.45%
1,031,310 $70.6 Million
Q4 2023

Feb 07, 2024
BUY
$48.64 - $57.81 $6.88 Million - $8.18 Million
141,514 Added 17.86%
933,710 $54 Million
Q3 2023

Nov 08, 2023
BUY
$50.19 - $54.68 $7.6 Million - $8.28 Million
151,507 Added 23.65%
792,196 $41.8 Million
Q2 2023

Aug 11, 2023
BUY
$49.72 - $54.64 $31.4 Million - $34.5 Million
631,413 Added 6806.95%
640,689 $34.7 Million
Q1 2023

May 10, 2023
BUY
$45.09 - $50.03 $48,201 - $53,482
1,069 Added 13.03%
9,276 $464,000
Q4 2022

Feb 09, 2023
SELL
$39.56 - $47.22 $34,535 - $41,223
-873 Reduced 9.61%
8,207 $379,000
Q3 2022

Nov 07, 2022
SELL
$36.71 - $109.66 $46,328 - $138,390
-1,262 Reduced 12.2%
9,080 $352,000
Q2 2022

Aug 09, 2022
BUY
$35.24 - $47.1 $45,036 - $60,193
1,278 Added 14.1%
10,342 $386,000
Q1 2022

May 10, 2022
BUY
$40.9 - $45.1 $43,967 - $48,482
1,075 Added 13.46%
9,064 $402,000
Q4 2021

Jan 21, 2022
BUY
$38.07 - $44.87 $19,720 - $23,242
518 Added 6.93%
7,989 $339,000
Q3 2021

Oct 28, 2021
SELL
$41.23 - $45.88 $31,582 - $35,144
-766 Reduced 9.3%
7,471 $324,000
Q2 2021

Jul 30, 2021
SELL
$38.58 - $44.24 $1,697 - $1,946
-44 Reduced 0.53%
8,237 $353,000
Q1 2021

Apr 12, 2021
SELL
$35.27 - $39.67 $81,050 - $91,161
-2,298 Reduced 21.72%
8,281 $320,000
Q4 2020

Jan 11, 2021
SELL
$33.15 - $41.97 $22,111 - $27,993
-667 Reduced 5.93%
10,579 $380,000
Q3 2020

Oct 30, 2020
SELL
$34.44 - $42.23 $22,489 - $27,576
-653 Reduced 5.49%
11,246 $430,000
Q2 2020

Jul 30, 2020
BUY
$30.19 - $39.11 $13,917 - $18,029
461 Added 4.03%
11,899 $418,000
Q1 2020

Apr 27, 2020
SELL
$25.83 - $45.71 $84,567 - $149,654
-3,274 Reduced 22.25%
11,438 $374,000
Q4 2019

Jan 17, 2020
BUY
$37.87 - $45.37 $97,288 - $116,555
2,569 Added 21.16%
14,712 $665,000
Q3 2019

Nov 01, 2019
SELL
$40.31 - $43.45 $25,193 - $27,156
-625 Reduced 4.9%
12,143 $494,000
Q2 2019

Jul 23, 2019
SELL
$34.91 - $42.98 $86,262 - $106,203
-2,471 Reduced 16.21%
12,768 $550,000
Q1 2019

Apr 09, 2019
SELL
$32.91 - $40.75 $11,255 - $13,936
-342 Reduced 2.19%
15,239 $585,000
Q4 2018

Jan 28, 2019
SELL
$31.73 - $39.04 $86,464 - $106,384
-2,725 Reduced 14.89%
15,581 $551,000
Q3 2018

Oct 18, 2018
SELL
$32.83 - $38.63 $63,887 - $75,173
-1,946 Reduced 9.61%
18,306 $705,000
Q2 2018

Jul 19, 2018
SELL
$26.84 - $34.32 $190,698 - $243,843
-7,105 Reduced 25.97%
20,252 $662,000
Q1 2018

Apr 30, 2018
SELL
$25.2 - $28.54 $691,236 - $782,852
-27,430 Reduced 50.07%
27,357 $747,000
Q4 2017

Feb 02, 2018
SELL
$24.79 - $29.8 $146,880 - $176,565
-5,925 Reduced 9.76%
54,787 $1.36 Million
Q3 2017

Oct 24, 2017
BUY
$26.26 - $29.17 $1.59 Million - $1.77 Million
60,712
60,712 $1.77 Million

Others Institutions Holding BSX

# of Institutions
1,832
Shares Held
1.21B
Call Options Held
9.66M
Put Options Held
6.98M
View Full List

About BOSTON SCIENTIFIC CORP

BSX Quotes by TradingView
  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $149B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Huntington National Bank Portfolio

Follow Huntington National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Huntington National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Huntington National Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email